Posted Thu, Sep, 13,2012
Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Endocrinology and Diabetes.
One of the ways we measure an article's visibility is the number of views and downloads it receives. The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibility figure.
Counting views and downloads is complicated by the possibility of fraud and automated views by search engines. To ensure that readers and authors can have confidence in our visibility analytics we have now formally joined Project Counter. Release 3 of Project Counter's code of practice addresses these and other problems.
Clinical Medicine Insights: Endocrinology and Diabetes' membership of Project Counter ensures that readers and authors can trust its visibility analytics.
Visit this page to see the latest visibility information for Clinical Medicine Insights: Endocrinology and Diabetes
Posted in: Open AccessVisibility and Discoverability
News Categories
Mon 20 May, 2013
Measuring Restriction Sizes Using DWIMon 20 May, 2013
Ozone Dose: Rest versus ExerciseMon 20 May, 2013
Genetic Risk Score Based Association AnalysisPublishing in “Clinical Medicine Insights: Oncology” was one of my best experience so far in an academic context. I found the process of going through submission, review, editing, and publication to be quite easy and most importantly, fair and efficient. I congratulate the team at Libertas Academica for a very well managed journal.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
Facebook Google+ Twitter
Pinterest Tumblr YouTube